Hepatitis Monthly

Published by: Kowsar

Serum Iron Markers in Patients With Chronic Hepatitis C Infection

Codruta Vagu 1 , Camelia Sultana 2 , 3 and Simona Ruta 2 , 3 , *
Authors Information
1 Department of Virology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
2 Emergent Diseases Department, Stefan S. Nicolau Institute of Virology, Bucharest, Romania
3 Discipline of Biochemistry, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Article information
  • Hepatitis Monthly: October 01, 2013, 13 (10); e13136
  • Published Online: October 5, 2013
  • Article Type: Brief Report
  • Received: June 24, 2013
  • Revised: September 12, 2013
  • Accepted: September 23, 2013
  • DOI: 10.5812/hepatmon.13136

To Cite: Vagu C, Sultana C, Ruta S. Serum Iron Markers in Patients With Chronic Hepatitis C Infection, Hepat Mon. 2013 ; 13(10):e13136. doi: 10.5812/hepatmon.13136.

Copyright © 2013, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussions
  • 1. Dehesa-Violante M, Nunez-Nateras R. Epidemiology of hepatitis virus B and C. Arch Med Res. 2007; 38(6): 606-11[DOI][PubMed]
  • 2. Veldt BJ, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, Zeuzem S, et al. Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis. Ann Intern Med. 2007; 147(10): 677-84[PubMed]
  • 3. Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000; 284(4): 450-6[PubMed]
  • 4. Franchini M, Targher G, Capra F, Montagnana M, Lippi G. The effect of iron depletion on chronic hepatitis C virus infection. Hepatol Int. 2008; 2(3): 335-40[DOI][PubMed]
  • 5. Mitsuyoshi H, Yasui K, Yamaguchi K, Minami M, Okanoue T, Itoh Y. Pathogenic Role of Iron Deposition in Reticuloendothelial Cells during the Development of Chronic Hepatitis C. Int J Hepatol. 2013; 2013: 686420[DOI][PubMed]
  • 6. Bonkovsky HL. Iron as a comorbid factor in chronic viral hepatitis. Am J Gastroenterol. 2002; 97(1): 1-4[DOI][PubMed]
  • 7. Fabris C, Toniutto P, Scott CA, Falleti E, Avellini C, Del Forno M, et al. Serum iron indices as a measure of iron deposits in chronic hepatitis C. Clin Chim Acta. 2001; 304(1-2): 49-55[PubMed]
  • 8. Metwally MA, Zein CO, Zein NN. Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am J Gastroenterol. 2004; 99(2): 286-91[PubMed]
  • 9. Di Bisceglie AM. Natural history of hepatitis C: its impact on clinical management. Hepatology. 2000; 31(4): 1014-8[DOI][PubMed]
  • 10. Poynard T, Muntenau M, Morra R, Ngo Y, Imbert-Bismut F, Thabut D, et al. Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update. Gastroenterol Clin Biol. 2008; 32(6 Suppl 1): 8-21[DOI][PubMed]
  • 11. Price L, Kowdley KV. The role of iron in the pathophysiology and treatment of chronic hepatitis C. Can J Gastroenterol. 2009; 23(12): 822-8[PubMed]
  • 12. Fujita N, Sugimoto R, Ma N, Tanaka H, Iwasa M, Kobayashi Y, et al. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C. J Viral Hepat. 2008; 15(7): 498-507[DOI][PubMed]
  • 13. Ramm GA, Ruddell RG. Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. Semin Liver Dis. 2005; 25(4): 433-49[DOI][PubMed]
  • 14. Buyukasik NS, Nadir I, Akin FE, Cakal B, Kav T, Ersoy O, et al. Serum iron parameters in cirrhosis and chronic hepatitis: detailed description. Turk J Gastroenterol. 2011; 22(6): 606-11[PubMed]
  • 15. Fujita N, Sugimoto R, Urawa N, Araki J, Mifuji R, Yamamoto M, et al. Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C. J Gastroenterol Hepatol. 2007; 22(11): 1886-93[DOI][PubMed]
  • 16. Lange CM, Kutalik Z, Morikawa K, Bibert S, Cerny A, Dollenmaier G, et al. Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon-alpha and ribavirin therapy. Hepatology. 2012; 55(4): 1038-47[DOI][PubMed]
  • 17. Liu H, Trinh TL, Dong H, Keith R, Nelson D, Liu C. Iron regulator hepcidin exhibits antiviral activity against hepatitis C virus. PLoS One. 2012; 7(10)[DOI][PubMed]
  • 18. Guyader D, Thirouard AS, Erdtmann L, Rakba N, Jacquelinet S, Danielou H, et al. Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C. J Hepatol. 2007; 46(4): 587-95[DOI][PubMed]
  • 19. Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology. 2010; 139(2): 393-408[DOI][PubMed]
  • 20. Cho H, Lee HC, Jang SK, Kim YK. Iron increases translation initiation directed by internal ribosome entry site of hepatitis C virus. Virus Genes. 2008; 37(2): 154-60[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments